Synergy Network
Synergy's Founding Partners, Network Partners and Partners Emeriti are ready to contribute their specific strategic, scientific and technical expertise as required to make your project successful.
- Synergy Founding Partners have deep expertise and long experience in overseeing successful drug discovery and development programs, working with clients to develop program strategy and overseeing the Synergy network contributions to program execution.
- Synergy Network Partners bring specific and deep subject matter expertise to contribute to program direction and to spearhead execution of the program plans.
- Synergy Network Partners Emeriti are colleagues with long and deep histories of successful drug development programs, both in their own careers and as consultants supporting client programs, and are available for additional support when issues arise.
Meet our Network:
|
Preclinical Research
W. Robert Bishop, PhD Harry R. Davis, PhD Jackson B. Gibbs, PhD William J. Greenlee, PhD Paul Kirschmeier, PhD Eric M. Parker, PhD John J. Piwinski, PhD Michael Rowley, PhD Catherine D. Strader, PhD Margaret van Heek, PhD Patricia C. Weber, PhD Emeriti Marvin L. Bayne, PhD Keith A. Bostian, PhD |
Chemistry, Manufacturing & Controls
Stéphane G. Ouellet , PhD Scott D. Reynolds, PhD William C. Schinzer, PhD John W. Skoug, PhD Mark VanArendonk, PhD Emeritus Gregory C. Davis, PhD |
Clinical, Regulatory & Project Management
Jo Ann Horowitz, MD Gina Johns, PMP, CPM Stacy Nelson, RAC Sharon C. Spence Emeriti Scott A. Reines, MD, PhD Eve E. Slater, MD |